
(March 2011 – September 2013)
Warning Letter / 483 Remediation
Global multi-million dollar In Vitro diagnostic Company in assays and assay instrument platforms as Global 3rd Party Risk Management Consultant – Train, mentor and implement risk management process compliant to ISO 14971 and modify Post-Market Notification process compliant to 21CFR Part 807 to support lifting FDA Warning Letter. (March 2011 – September 2013)
Project Lead, 483 remediation efforts in Risk Management
Author/Mentor
- Training content, assessment test development
- Delivered training on ISO 14971, fundamentals of FMEAs, and risk assessments to engineers, quality assurance personnel, and management
- Delivered classroom training and exercises on new risk management process
- Identified, trained, mentored and certified Risk Managers and Specialists at multiple global sites
- Cross functional project teams during design change and risk documentation development
- Review, red-line, and approve over a thousand risk documents including FMEAs (use, design, and process), risk assessments, risk management plans/reviews/reports, and system risk assessments in accordance with FDA obligated interim controls
Manage Resources and Timelines
- Global effort to sunset FDA obligated interim controls
Project Team, 483 remediation efforts in Pre-Market Notification
Author/Mentor
- Process mapping of design change and pre-market notification processes
- Reviewed, red-lined, and approved new pre-market notification procedures and decision trees compliant to 21CFR Part 807 Subpart E/809/814/860/862/864/866
- Reviewed, red-lined and approved training content and assessment tests
Back to Projects